tetrandrine has been researched along with Leukemia, Megakaryocytic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Z; Li, W; Liu, T; Wu, G; Xu, X; Yu, C; Zeng, C; Zhang, Z | 1 |
1 other study(ies) available for tetrandrine and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autophagy; Benzylisoquinolines; Cell Differentiation; CRISPR-Cas Systems; Female; Gene Knockout Techniques; Humans; K562 Cells; Leukemia, Megakaryoblastic, Acute; Mice; Mice, Nude; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2017 |